Rocket Pharmaceuticals (RCKTW) Competitors $0.0088 0.00 (-11.12%) As of 09:30 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock RCKTW vs. AIMDW, ALVOW, ARAV, ACABW, and RNAShould you buy Rocket Pharmaceuticals stock or one of its competitors? MarketBeat compares Rocket Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rocket Pharmaceuticals include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry. RCKTW vs. AIMDWRCKTW vs. ALVOWRCKTW vs. ARAVRCKTW vs. ACABWRCKTW vs. RNAHow does Rocket Pharmaceuticals compare to Ainos?Ainos (NASDAQ:AIMDW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk. Which has preferable valuation and earnings, AIMDW or RCKTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$18.11KN/AN/AN/AN/ARocket PharmaceuticalsN/AN/AN/AN/AN/A Is AIMDW or RCKTW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A Rocket Pharmaceuticals N/A N/A N/A Does the media favor AIMDW or RCKTW? In the previous week, Ainos had 1 more articles in the media than Rocket Pharmaceuticals. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Rocket Pharmaceuticals. Ainos' average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score. Company Overall Sentiment Ainos Neutral Rocket Pharmaceuticals Neutral SummaryAinos beats Rocket Pharmaceuticals on 2 of the 2 factors compared between the two stocks.How does Rocket Pharmaceuticals compare to Alvotech?Alvotech (NASDAQ:ALVOW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability. Is ALVOW or RCKTW more profitable? Company Net Margins Return on Equity Return on Assets AlvotechN/A N/A N/A Rocket Pharmaceuticals N/A N/A N/A Does the media refer more to ALVOW or RCKTW? In the previous week, Alvotech's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score. Company Overall Sentiment Alvotech Neutral Rocket Pharmaceuticals Neutral Which has preferable earnings and valuation, ALVOW or RCKTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$586.32MN/AN/AN/AN/ARocket PharmaceuticalsN/AN/AN/AN/AN/A SummaryAlvotech beats Rocket Pharmaceuticals on 1 of the 1 factors compared between the two stocks.How does Rocket Pharmaceuticals compare to Aravive?Aravive (NASDAQ:ARAV) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Do institutionals and insiders hold more shares of ARAV or RCKTW? 35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, ARAV or RCKTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAraviveN/AN/AN/A-$0.90N/ARocket PharmaceuticalsN/AN/AN/AN/AN/A Is ARAV or RCKTW more profitable? Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A Rocket Pharmaceuticals N/A N/A N/A Does the media favor ARAV or RCKTW? In the previous week, Aravive's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score. Company Overall Sentiment Aravive Neutral Rocket Pharmaceuticals Neutral SummaryAravive beats Rocket Pharmaceuticals on 2 of the 2 factors compared between the two stocks.How does Rocket Pharmaceuticals compare to Atlantic Coastal Acquisition Corp. II?Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings. Which has preferable valuation & earnings, ACABW or RCKTW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/ARocket PharmaceuticalsN/AN/AN/AN/AN/A Is ACABW or RCKTW more profitable? Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. IIN/A N/A N/A Rocket Pharmaceuticals N/A N/A N/A Does the media prefer ACABW or RCKTW? In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score. Company Overall Sentiment Atlantic Coastal Acquisition Corp. II Neutral Rocket Pharmaceuticals Neutral SummaryAtlantic Coastal Acquisition Corp. II and Rocket Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.How does Rocket Pharmaceuticals compare to Avidity Biosciences?Avidity Biosciences (NASDAQ:RNA) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Which has stronger valuation and earnings, RNA or RCKTW? Rocket Pharmaceuticals has lower revenue, but higher earnings than Avidity Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvidity Biosciences$36.68M6.04-$322.30MN/AN/ARocket PharmaceuticalsN/AN/AN/AN/AN/A Does the media refer more to RNA or RCKTW? In the previous week, Avidity Biosciences had 5 more articles in the media than Rocket Pharmaceuticals. MarketBeat recorded 5 mentions for Avidity Biosciences and 0 mentions for Rocket Pharmaceuticals. Avidity Biosciences' average media sentiment score of 0.80 beat Rocket Pharmaceuticals' score of 0.00 indicating that Avidity Biosciences is being referred to more favorably in the media. Company Overall Sentiment Avidity Biosciences Positive Rocket Pharmaceuticals Neutral Do analysts rate RNA or RCKTW? Avidity Biosciences presently has a consensus target price of $69.42, suggesting a potential upside of 436.07%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Avidity Biosciences is more favorable than Rocket Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avidity Biosciences 1 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.37Rocket Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is RNA or RCKTW more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Rocket Pharmaceuticals' return on equity of 0.00% beat Avidity Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Avidity Biosciences-3,650.39% -44.92% -39.57% Rocket Pharmaceuticals N/A N/A N/A SummaryAvidity Biosciences beats Rocket Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RCKTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKTW vs. The Competition ExportMetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$465.73M$6.25B$12.23BDividend YieldN/A3.87%2.80%5.32%P/E RatioN/A3.7620.7925.05Price / SalesN/A7,435.94531.2172.69Price / CashN/A13.1343.0954.25Price / BookN/A83.539.816.83Net IncomeN/A-$96.07M$3.55B$335.69M7 Day PerformanceN/A0.52%-2.07%-2.03%1 Month PerformanceN/A0.18%-3.90%-1.90%1 Year PerformanceN/A71.17%29.39%27.36% Rocket Pharmaceuticals Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCKTWRocket PharmaceuticalsN/A$0.01-11.1%N/A-81.7%$0.00N/AN/A240AIMDWAinosN/A$0.10+3.0%N/A-54.3%$0.00$124.16KN/A40News CoverageALVOWAlvotechN/A$0.20flatN/A-87.9%$0.00$586.32MN/A4Gap UpARAVAraviveN/A$0.04flatN/AN/A$0.00N/AN/A20High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.00flatN/AN/A$0.00N/AN/A15 Related Companies and Tools Related Companies AIMDW Alternatives ALVOW Alternatives ARAV Alternatives ACABW Alternatives RNA Alternatives BFRIW Alternatives CALA Alternatives CELUW Alternatives CINGW Alternatives CMRAW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCKTW) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
